PHARMACOGENETIC TESTING TO SELECT ANALGESICS: CAN WE IMPROVE SAFETY?
TRANSLATION TO CLINICAL PRACTICE OF THE RESULTS OF CLINICAL TRIALS: THE EXAMPLE OF CHONDROITIN SULPHATE
EVIDENCE-BASED MEDICINE (EBM): INHERENT LIMITATIONS AND PERVERSION OF THE MESSAGE
DRUG SUBSTITUTION POLICIES: ARE THEY INTERCHANGEABLE GENERICS AND BIOSIMILARS? UNFAVORABLE ASPECTS
BIOSIMILARS: NO ‘EVIDENCE-BASED’ CONCERNS
BIOSIMILARS: LIMITATIONS FOR THE USE OF SUBSTITUTION POLICIES
EVALUATION OF PHARMACOLOGICAL INTERVENTIONS WITH THE GRADE SYSTEM: AN EMERGING CONSENSUS
REGULATORY AND DRUG UTILITY ASSESSMENT AS A CONTINUUM AND COORDINATED EFFORT: HOW RESOURCES AND USE OF EXPERTISE COULD BE OPTIMISED
A FOLLOW-UP OF PATIENTS TREATED WITH ANTIPSYCHOTICS: THE ICARO STUDY
DIFFERENCES IN THE DETECTION OF ADVERSE DRUG REACTIONS BETWEEN SERVICES IN A TERTIARY REFERRAL HOSPITAL
HOSPITAL PHARMACOVIGILANCE UNITS. OPPORTUNITIES AND DRAWBACKS THE SPANISH DRUG-INDUCED LIVER INJURY (DILI) REGISTRY: A MODEL OF RESEARCH GOING FROM BEDSIDE TO BENCH
HOSPITAL PHARMACOVIGILANCE UNITS: EXPERIENCES AND DIFFICULTIES
ASSESSMENT OF ANTI-TNF DOSE REDUCTION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: AN INDEPENDENT COLLABORATIVE CLINICAL TRIAL
CARDIOVASCULAR RISK AND DRUGS
TOTAL KNEE REPLACEMENT AS AN OSTEOARTHRITIS STUDY OUTCOME: PREDICTORS DERIVED FROM LONG-TERM OBSERVATION FOLLOWING A RANDOMIZED CLINICAL TRIAL
PROGRESSIVE MULTIPHOCAL LEUCOENCEPHALOPATHY (PML) ASSOCIATED WITH THE INITIATION OF ANTIRETROVIRAL THERAPY
ALBATROSS-II - A LOCALLY INJECTED BRADYKININ ANTAGONIST FOR TREATMENT OF OSTEOARTHRITIS. AN ONGOING, SEQUENTIAL ASCENDING-DOSE STUDY, TO EVALUATE THE SAFETY, TOLERABILITY, PK AND PD OF INTRA-ARTICULAR DOSES OF FASITIBANT INPATIENTS WITH SYMPTOMATIC OSTEOARTHRITIS OF THE KNEE
IVRS/IWRS OFFERED OPPORTUNITIES IN CLINICAL TRIALS: REMOVAL OF USE-BY-DATES FROM IMP LABELS AND PROGRAM POOLING
PAEDIATRICS CLINICAL TRIALS AT THE UNIVERSITY HOSPITAL VALL D'HEBRON (PERIOD 2004-2011)
CONDROITIN SULFATE DECREASES CHEMOKINE LEVELS AND SYNOVITIS IN KNEE OA PATIENTS
MULTICENTRIC OBSERVATIONAL STUDY OF ACUTE RENAL FAILURE ASSOCIATED TO RENIN-ANGIOTENSIN SYSTEM INHIBITORS
HOSPITAL ADMISSIONS DUE TO VENOUS THROMBOEMBOLIC EVENTS ASSOCIATED TO HORMONAL CONTRACEPTION USE
IMPORTANCE OF THE HISTORY OF INFIRMARY IN A PHASE UNIT I
DRUG-RELATED ACUTE RENAL FAILURE IN HOSPITALIZED PATIENTS
BILIRUBIN AS SURROGATE MARKER FOR TOXICITY AND EXPOSURE TO ATAZANAVIR
CHANGING SERUM CREATININE LEVELS IN PATIENTS RECEIVING DIGOXIN
ASSESSMENT OF THE BLOOD POTASSIUM AND RATIO K/NA IN PATIENTS ON DIGOXIN
RISK OF TROMBOVASCULAR EVENTS IN PATIENTS ON CLOZAPINE
PREVALENCE OF LOW VIT B12 PLASMA LEVELS IN PATIENTS WITH DEPRESSIVE SYMPTOMS
SSCHIZOPHRENIA: INFLUENCE OF SINGLE NUCLEOTIDE POLYMORPHISMS ON PEPTIDIC SEQUENCES
INFLUENCE OF ANTIPSYCHOTIC TREATMENT ON C3, C4 COMPONENTS OF COMPLEMENT SYSTEM
INFLUENCE OF LONG-TERM ANTIPSYCHOTIC TREATMENT ON INMUNOGLOBULIN PLASMA CONCENTRATION
IMPROVED DEFINITION OF HY's LAW FOR PREDICTING DILI-INDUCED ACUTE LIVER FAILURE (ALF)
DRUG-INDUCED DILATED CARDIOMYOPATHY
EPIDEMIOLOGY OF IN-HOSPITAL AGRANULOCYTOSIS IN BARCELONA (1981-2011)
GENETIC VARIATIONS IN HLA GENES AFFECT THE PRESENTATION OF AMOXICILLIN-CLAVULANTE INDUCED LIVER INJURY (A-C DILI)
MULTIPLE HEPATOTOXICITY EPISODES ARE FREQUENTLY ASSOCIATED WITH AUTOIMMUNE PRESENTATION
IERACAT COHORT STUDY: EFFECTIVENESS OF INHIBITORS OF THE RENIN-ANGIOTENSIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND HYPERTENSION IN CATALONIA
COMMUNITY-ACQUIRED PNEUMONIA IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE TREATED WITH BRONCHODILATORS OR OTHER INHALED CORTICOSTEROIDS (STUDY PNEUMOCORT). FIRST PHASE: FORMATION OF THE COHORT AND BASELINE DATA
ADVERSE REACTIONS ASSOCIATED TO DABIGATRAN IDENTIFIED THROUGH SPONTANEOUS REPORTING SYSTEM
OFF-LABEL DRUGS AND SCIENTIFIC EVIDENCE
ANALYSIS OF THE QUALITY OF APPLICATIONS FOR AUTHORISATION OF CLINICAL TRIALS ON MEDICINAL PRODUCT (CTA) RECEIVED IN THE AGENCIA ESPAÑOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS (AEMPS) BETWEEN 2009 AND 2011
OVERVIEW OF THE CLINICAL TRIALS (CT) TEMPORARILY HALTED DURING THE YEAR 2011
OVERVIEW OF CLINICAL TRIALS (CT) EARLY TERMINATED DURING THE YEAR 2011
IMPROVING QUALITY OF PRESCRIPTION IN PRIMARY CARE HEALTH CENTER THROUGH A THERAPEUTIC INTERVENTION WITH EQUIVALENT DRUGS: PRELIMINARY RESULTS
DRUGS FOR ALZHEIMER's DISEASE: DESCRIPTION OF THE POPULATION TREATED IN CATALONIA AND IMPACT OF NEW PHARMACEUTICAL FORMS IN ITS PRESCRIPTION PROFILE
POTENTIALLY PREVENTABLE ADVERSE DRUG REACTIONS: LONG WAY TO GO
CAUSALITY ASSESSMENT OF ADVERSE DRUG REACTIONS: COMPARISON OF THREE METHODS
ASEPTIC MENINGITIS NOTIFIED TO THE SPANISH PHARMACOVIGILANCE SYSTEM
TREATMENT DISCONTINUATION IN CLINICAL TRIALS OF METHYLPHENIDATE AND ATOMOXETINE FOR ADULTS WITH ATTENTION DEFICIT/HYPERACTIVITY DISORDER: A SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICAL TRIALS.
BISPHOSPHONATES OVER 5 YEARS: INTERVENTION TO IMPROVE ADEQUACY
ARE RE-LY PATIENTS SIMILAR TO THE REAL ONES?
APPLICATION OF PHARMACODYNAMIC PRINCIPLES (AUC/MIC) TO IMPROVE CLINICAL EFFICACY IN INDIVIDUAL TREATMENT WITH VANCOMYCIN
AVOIDABLE SEVERE HYPERKALEMIA IN HIGH-RISK PATIENT
PHARMACOKINETIC STUDY TO ASSESS THE INTERACTION BETWEEN SUNITINIB (SUN) AND KETOCONAZOL (KET) TO REDUCE THE DOSE AND COST OF SUNITINIB
SENTIA: ONLINE SPANISH SAFETY REGISTRY FOR NEUROLEPTIC TREATMENT IN CHILDREN AND ADOLESCENTS. RESULTS FROM 1 YEAR FOLLOW-UP STUDY
MYOCLONUS AND FLUOXETINE IN A CHILD
PHARMACOGENETICS OF IMMUNOSUPPRESSANTS
ACTIVITY OF THE CLINICAL TRIALS UNIT (CTU) AT THE HOSPITAL RAMON Y CAJAL AND SATISFACTION OF THE PATIENTS/HEALTHY VOLUNTEERS AND INVESTIGATORS THAT HAVE USED IT
UTILITY OF A BAYESIAN-BASED ASSESMENT TOOL FOR THE EARLY DIAGNOSIS OF DRUG INDUCED LIVER INJURY
EVALUATION OF THE PROPER USE OF TRANSFUSION OF BLOOD COMPONENTS IN EMERGENCY DEPARTMENTS: RESULTS OF THE FIRST PHASE
VANCOMYCIN-INDUCED ACUTE KIDNEY INJURY DETECTED BY A PROSPECTIVE PHARMACOVIGILANCE PROGRAM FROM LABORATORY SIGNALS
IMPROVING THE SUITABILITY OF LINEZOLID USE DECREASES THE INCIDENCE OF LINEZOLID RESISTANCE AMONG GRAM-POSITIVES
PARACETAMOL INTOXICATION IN A RETROSPECTIVE COHORT IN A TERTIARY HOSPITAL
DEVELOPMENT AND VALIDATION OF A TOXICOVIGILANCE SYSTEM WITH AUTOMATIC DETECTION OF CASES
DIFFERENCES BETWEEN PEDIATRIC AND ADULT POPULATIONS HAVING DRUG INDUCED AGRANULOCYTOSIS
PROTON PUMP INHIBITORS (PPIS) REDUCE NEUTROPHIL BACTERICIDAL CAPACITY IN PATIENTS WITH CIRRHOSIS AND ASCITES INDEPENDENTLY OF THE SIMULTANEOUS USE OF NORFLOXACIN
INTENSIFIED ANTI-TNF-ALPHA DOSING IS MORE FREQUENT IN PATIENTS WITH MUTATED NOD2/ATG16L1-COMBINED GENOTYPES
PILOT STUDY ON THE ACUTE PAIN MANAGEMENT IN EMERGENCIES
DRUG INTERACTIONS OF DABIGATRAN: REPORT OF ONE CASE
NURSE ROLE DEVELOPMENT AT A RESEARCH CENTRE FOR A PHASE I IN A TERTIARY HOSPITAL
CLINICAL EXPERIENCE WITH NEW-GENERATION ANTIRETROVIRAL THERAPIES IN HIV PATIENTS WITH VIROLOGICAL FAILURE: 96 WEEKS ASSESSMENT
COMPARATIVE BIOAVAILABILITY BETWEEN DIFFERENT ORAL FORMULATIONS OF DEXKETOPROFEN TROMETAMOL 25 MG IN HEALTHY VOLUNTEERS
POLYPODIUM LEUCOTOMOS EXTRACT IN ATOPIC DERMATITIS: RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED AND MULTICENTER CLINICAL TRIAL
SYNERGISTIC CHONDROPROTECTIVE EFFECT OF CHONDROITIN SULFATE AND GLUCOSAMINE: A PHARMACOPROTEOMIC STUDY
EXPRESSION OF SPECIFIC PATHWAYS IN THE INFLAMED SYNOVIAL MEMBRANE OF OSTEOARTHRITIS PATIENT: IDENTIFICATION OF NEW POTENTIAL KEY INTERMEDIATES
MILDLY DRUG-INDUCED ELEVATED LIVER TRANSAMINASE LEVELS IN PRIMARY CARE
ACUTE EFFECTS OF DIPYRONE ON RENAL FUNCTION IN PATIENTS WITH CIRRHOSIS
CONCENTRATIONS OF ATOMOXETINE IN PLASMA, ORAL FLUID AND SWEAT FROM PAEDIATRIC PATIENTS WITH ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)
HEPATOBILIARY DISORDERS ASSOCIATED WITH RIVASTIGMINE: SPONTANEOUS REPORTING AND LITERATURE REVIEW
RANDOMIZED CONTROLLED, DOUBLE BLIND TRIAL OF TOPICAL TWICE WEEKLY FLUTICASONEP PROPIONATE MAINTENANCE TREATMENT TO REDUCED RISK OF RELAPSE IN MILD OR MODERATE ATOPIC DERMATITIS (AD) IN CHILDREN
EXPERIENCE IN THERAPEUTIC MONITORING OF VANCOMYCIN IN ADULT PATIENTS UNDERGOING CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD), 2010-2012
ABSORPTION OF DESLORATADINE 5 MG ORODISPERSIBLE TABLETS VERSUS PLAIN TABLETS
TRUNCATED AREA UNDER THE CURVE ON THE EVALUATION OF BIOEQUIVALENCE IN LONG HALF-LIFE DRUGS
THERAPEUTIC UTILITY REPORT: NEW ORAL ANTICOAGULANTS FOR PREVENTION OF STROKE AND SYSTEMIC EMBOLISM IN NON-VALVULAR ATRIAL FIBRILLATION
NEW ORAL ANTICOAGULANTS VERSUS WARFARIN ON PRIMARY AND SECONDARY PREVENTION OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION: A METAANALYSIS
EFFECT OF CHONDROITIN SULFATE ON THE FACTORS INVOLVED IN SYNOVIAL INFLAMMATION
EVALUATION OF THE RELATIONSHIP BETWEEN POLYMORPHISMS IN CYP2C19 AND PHARMACOKINETICS OF THE PROTON PUMP INHIBITORS
EVOLUTION OF STUDIES PRESENTED AT THE HOSPITAL UNIVERSITARIO DE LA PRINCESA DURING THE PERIOD 2004-2012
ANTIPSYCHOTICS PRESCRIPTION PATTERN IN A MENTAL HEALTH HOSPITAL WARD: EVIDENCE VERSUS PRAXIS
EXPERT PSYCHOPHARMACOLOGIC RECOMMENDATIONS FOLLOW-UP AND ITS BEHAVIORAL IMPACT ON INTELLECTUAL DISABILITY PATIENTS
VALUE OF ‘TDM’ FOR CLINICAL CONTROL OF MULTIPLE DRUG INTERACTION IN AN HIV POSITIVE PATIENT WITH LIVER TRANSPLANTATION
UBIDECARENONE AS A DIAGNOSTIC MARKER AND POSSIBLE TREATMENT IN FIBROMYALGIA
CONTRACEPTIVE MEASURES INCLUDED IN THE CLINICAL TRIALS INFORMATION
RHABDOMYOLYSIS SECONDARY TO A DRUG INTERACTION BETWEEN RITONAVIR AND SIMVASTATIN IN A PATIENT WITH A LIVER TRANSPLANT
CYP4F2 AND APOE CONTRIBUTION IN ACENOCOUMAROL DOSING BASED ON GENOTYPE: A COMPARISON OF TWO ALGORITHMS
OPIOID-INDUCED ERECTILE DYSFUNCTION: EARLY DETECTION, EVALUATION AND TREATMENT
HYPNOTICS AND MORTALITY: A SYSTEMATIC REVIEW OF LITERATURE
MUSCULOSKELETAL SYMPTOMS ASSOCIATED WITH BISPHOSPHONATES. A RETROSPECTIVE FOLLOW-UP STUDY WITH INFORMATION FROM THE HEALTH IMPROVEMENT NETWORK (THIN)
METAMIZOL-INDUCED AGRANULOCYTOSIS: A CASE/NON-CASE STUDY OF SUSPECTED ADVERSE DRUG REACTIONS IN VIGIBASE
ANTIDIABETIC-INDUCED ADVERSE REACTIONS: DATA MINING TO EXPLORE NEW SIGNALS WITH INFORMATION COMING FROM SPONTANEOUS REPORTS
THE RELATIONSHIP BETWEEN GENE CYP2C9 AND UPPER GASTROINTESTINAL BLEEDING: ARE STUDIES PROPERLY DESIGNED?
DRUG UTILIZATION STUDY OF ANTI-ACID THERAPY IN HOSPITAL UNIVERSITARIO DE LA PRINCESA - MADRID
ETHANOL PHARMACOKINETICS, SUBJECTIVE EFFECTS AND PSYCHOMOTOR PERFORMANCE AFTER DRINKING DIFFERENT ALCOHOLIC BEVERAGES
PROGRESS OF CONSUMPTION PATTERNS OF DRUG ABUSE IN PATIENTS ADMITTED TO A HOSPITAL MENTAL HEALTH UNIT
PSYCHOLOGICAL ASSESSMENT IN THE INDICATION OF IMPLANTABLE THERAPIES IN CHRONIC PAIN
ANTIPSYCHOTIC DRUGS IN COCAINE DEPENDENCE: A SYSTEMATIC REVIEW AND META-ANALYSIS
GENETIC PROFILES OF CLINICAL RESPONSE TO OPIOID ANALGESICS
PROGNOSTIC SIGNIFICANCE OF NEW BIOLOGICAL MARKERS IN CHRONIC LYMPHOCYTIC LEUKAEMIA
NEW BEERS CRITERIA FOR POTENTIALLY INAPPROPRIATE MEDICATION USE: APPLICABILITY AND COMPARATIVE ANALYSIS WITH 2003 BEERS AND STOPP TOOLS
NEW PSYCHOACTIVE DRUGS IN SPAIN: RESULTS OF TWO SURVEYS
JACOBSON's PROGRESSIVE MUSCLE RELAXATION AS ADJUNCTIVE THERAPY IN OSTEOARTICULAR CHRONIC PAIN
RELANTIONSHIP BETWEEN INITIAL OR TOTAL DOSE AND LENTH OF STAY AMONG PATIENTS TREATED WITH SC OR IV FUROSEMIDE
EVALUATION OF LONG TERM PAEDIATRIC ANTHRACYCLINES-INDUCED CARDIOTOXICITY
PHASE I/II CLINICAL TRIAL OF INTRAMUSCULAR IMPLANTATION OF AUTOLOGOUS BONE MARROW STEM CELLS IN AMYOTROPHIC LATERAL SCLEROSIS PATIENTS